Belgian Biotech Raises €35M to Develop Eco-Friendly Pesticides
The Belgium-based company AgroSavfe has raised a Series C round of €35M to develop an…
July 30, 2019 - 2 minutes
Belgium
Scientists in Belgium Cure Anthrax in Mice by Smashing Bacteria’s Armor
Belgian researchers have developed a potential treatment for anthrax that breaks down the bacteria’s thick…
July 17, 2019 - 2 minutes
Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure
The Belgian company Imcyse has raised €35M in a Series B round to develop a…
June 18, 2019 - 2 minutes
Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets
Confo Therapeutics has raised €30M in a Series A round that will take its unique…
May 7, 2019 - 3 minutes
Viruses Evolve to Defeat CRISPR-Cas9 in Genetically-Modified Plants
Researchers found that viral pathogens can quickly evolve to overcome transgenic cassava plants expressing the…
April 29, 2019 - 2 minutes
AACR 2019: European Biotech Progresses in Fighting Cancer
The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the…
April 8, 2019 - 4 minutes
€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies
The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to…
April 3, 2019 - 2 minutes
Galapagos Nears First Drug Approval with Phase III Success in Rheumatoid Arthritis
Galapagos has released positive data from two phase III trials testing its flagship drug candidate,…
March 29, 2019 - 3 minutes
Artificial Intelligence Detects Juvenile Arthritis in the Blood
Using artificial intelligence, a Belgian research group can diagnose juvenile arthritis from blood samples with…
March 13, 2019 - 3 minutes
CAR-T Promise for Patients with Solid Tumors
A new CAR-T cancer therapy from the Belgian company Celyad has shown early positive results…
November 14, 2018 - 3 minutes
Belgian Biotech to Abandon Phase III Cell Therapy Trial for Bone Disease
Bone Therapeutics is going to discontinue its cell therapy Phase III trial after finding little…
November 7, 2018 - 2 minutes
Belgian Firm Will Develop Antibiotic Alternatives for Industrial Biotech Using CRISPR
Syngulon will be developing antibacterial peptides using CRISPR/Cas9 gene editing technology thanks to an agreement…
October 17, 2018 - 2 minutes
